SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $38,000 | -55.8% | 1,600 | -38.5% | 0.01% | -56.0% |
| Q2 2019 | $86,000 | -85.9% | 2,600 | -85.4% | 0.02% | -69.5% |
| Q1 2019 | $612,000 | +119.4% | 17,842 | +107.0% | 0.08% | -8.9% |
| Q4 2018 | $279,000 | -22.5% | 8,621 | +19.7% | 0.09% | +32.4% |
| Q3 2018 | $360,000 | +76.5% | 7,201 | +106.2% | 0.07% | +47.8% |
| Q2 2018 | $204,000 | +51.1% | 3,493 | +2.7% | 0.05% | +48.4% |
| Q4 2017 | $135,000 | +2150.0% | 3,400 | +1600.0% | 0.03% | +3000.0% |
| Q1 2017 | $6,000 | -95.2% | 200 | -95.9% | 0.00% | -93.8% |
| Q4 2016 | $124,000 | -65.9% | 4,900 | -72.6% | 0.02% | -68.0% |
| Q2 2016 | $364,000 | -64.6% | 17,891 | -73.5% | 0.05% | -58.0% |
| Q1 2016 | $1,029,000 | +97.9% | 67,491 | +74.4% | 0.12% | +83.1% |
| Q4 2015 | $520,000 | -47.6% | 38,696 | -45.3% | 0.06% | -43.0% |
| Q3 2015 | $992,000 | – | 70,705 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |